Previous close | 2.3800 |
Open | 2.3800 |
Bid | 0.8000 |
Ask | 3.9000 |
Strike | 36.00 |
Expiry date | 2024-06-07 |
Day's range | 2.3800 - 2.3800 |
Contract range | N/A |
Volume | |
Open interest | 89 |
The board of Baxter International Inc. ( NYSE:BAX ) has announced that it will pay a dividend of $0.29 per share on the...
DEERFIELD, Ill., May 29, 2024--Baxter International Inc. (NYSE:BAX), a global innovator in kidney care and vital organ support, today announced new data showing expanded hemodialysis, known as HDx therapy, enabled by Theranova dialyzer, was associated with an approximately 25% lower all-cause mortality risk for up to four years when compared to high-flux hemodialysis (HF HD). The study, "Survival of expanded hemodialysis and high-flux hemodialysis patients in Colombia: a cohort study," was prese
Baxter International's (BAX) robust growth across all geographies, along with transformational initiatives, boosts confidence. However, pandemic-related disruption continues to hurt sales.